Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Advanced Cancer 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Chlorogenic Acid × Clear all
NCT02245204 2018-11-21

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
8 enrolled

Advanced Cancer

NCT02728349 2018-11-01

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
26 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡